Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameCOBAS 4800 BRAF V600 MUTATION TEST
Classification Namesomatic gene mutation detection system
ApplicantROCHE MOLECULAR SYSTEMS, INC.
PMA NumberP110020
Date Received04/25/2011
Decision Date08/17/2011
Product Code
OWD[ Registered Establishments with OWD ]
Docket Number 11M-0601
Notice Date 08/19/2011
Advisory Committee Immunology
Clinical Trials NCT01107418
Expedited Review Granted? No
Combination Product Yes
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the cobas 4800 braf v600 mutation test. This device is indicated for: the cobas 4800 braf v600 mutation test is an in vitro diagnostic device intended for the qualitative detection of the braf v600e mutation in dna extracted from formalin-fixed, paraffin-embedded human melanoma tissue. The cobas 4800 braf v600 mutation test is a real-time pcr test on the cobas 4800 system, and is intended to be used as an aid in selecting melanoma patients whose tumors carry the braf v600e mutation for treatment with vemurafenib.
Approval Order Approval Order
Supplements: S001 S002 S003 S004 S005 S006 
-
-